ASE Test, Inc. - Mar 10, 2025 Form 4 Insider Report for Ainos, Inc. (AIMD)

Role: 10%+ Owner
Signature: /s/ Alan Li, By: ASE Test, Inc., By: Alan Li, authorized signatory of ASE Test, Inc.
Stock symbol: AIMD
Transactions as of: Mar 10, 2025
Transactions value $: $0
Form type: 4
Date filed: 3/12/2025, 06:02 AM
Previous filing: May 8, 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AIMD	6% Convertible Note due 2027 (previously due 2025)	Purchase		+499K			499K	Mar 10, 2025	Common Stock, par value $0.01	499K	$4.50	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The convertible notes with respect to shares of common stock, $0.01 par value (the "Common Stock"), of Ainos, Inc., a Texas corporation (the "Issuer") reported herein are directly held by ASE Test, Inc., an indirectly wholly-owned subsidiary of ASE Technology Holding Co., Ltd. Accordingly, ASE Technology Holding Co., Ltd. is reporting indirect ownership of the securities held by ASE Test, Inc.
F2	As previously reported, the Issuer and ASE Test, Inc. entered into a Convertible Promissory Note Purchase Agreement, dated March 13, 2023 (the "2023 Agreement"), pursuant to which the Issuer issued convertible promissory notes to ASE Test, Inc. in the principal amount of $2,000,000 (the "Principal Amount") and six percent (6%) compounded interest of which was due on March 13, 2025. On March 10, 2025, the Issuer and ASE Test, Inc. entered into an amendment to the 2023 Agreement (the "2023 Agreement Amendment") to extend the maturity date to March 12, 2027 and change the conversion price from $7.50 per share to a conversion price equal to the lower of (a) $7.50 per share and (b) the higher of (x) the average closing price per share of the Issuer's common stock for the period of thirty (30) trading days prior to the day when the ASE Test, Inc. exercises the conversion right or (y) $4.50, subject to anti-dilutive adjustment as set forth in the 2023 Agreement Amendment.

Content

The convertible notes with respect to shares of common stock, $0.01 par value (the "Common Stock"), of Ainos, Inc., a Texas corporation (the "Issuer") reported herein are directly held by ASE Test, Inc., an indirectly wholly-owned subsidiary of ASE Technology Holding Co., Ltd. Accordingly, ASE Technology Holding Co., Ltd. is reporting indirect ownership of the securities held by ASE Test, Inc.

As previously reported, the Issuer and ASE Test, Inc. entered into a Convertible Promissory Note Purchase Agreement, dated March 13, 2023 (the "2023 Agreement"), pursuant to which the Issuer issued convertible promissory notes to ASE Test, Inc. in the principal amount of $2,000,000 (the "Principal Amount") and six percent (6%) compounded interest of which was due on March 13, 2025. On March 10, 2025, the Issuer and ASE Test, Inc. entered into an amendment to the 2023 Agreement (the "2023 Agreement Amendment") to extend the maturity date to March 12, 2027 and change the conversion price from $7.50 per share to a conversion price equal to the lower of (a) $7.50 per share and (b) the higher of (x) the average closing price per share of the Issuer's common stock for the period of thirty (30) trading days prior to the day when the ASE Test, Inc. exercises the conversion right or (y) $4.50, subject to anti-dilutive adjustment as set forth in the 2023 Agreement Amendment.